Loading provider…
Loading provider…
Neurology Physician in Cooperstown, NY
NPI: 1396834446Primary Practice Location
BASSETT HEALTHCARE
1 Atwell Rd, Cooperstown, NY
Primary Employer
Massachusetts General Physicians Organization Inc
massgeneral.org
HQ Phone
Get MD Farrah's Phone Numberphone_androidMobile
Get MD Farrah's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
MD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99223Initial hospital inpatient care, typically 70 minutes per day | 34 | 34 |
| 2 | 99285Emergency department visit, problem with significant threat to life or function | 33 | 33 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 25 | 33 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 23 | 38 |
Causes and outcomes of persistent vegetative state in a Chinese versus American referral hospital.
Authors: Mateen, Farrah J, Niu, Jing-Wen, Gao, Shan, Li, Shun-Wei, Carone, Marco, Wijdicks, Eelco F M, Xu, Wei-Hai
Journal: Neurocrit Care
Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians.
Cerebrovascular accidents indicative of COVID-19 infection: about 4 observations in Guinea.
Authors: Atakla, Hugues Ghislain, Condé, Kaba, Neishay, Ayub, Barry, Lounceny Fatoumata, Bah, Aissatou Kenda, Konaté, Mamady, Diallo, Mamadou Hady, Mateen, Farrah Jasmine, Cissé, Fodé Abass
Journal: Pan Afr Med J
Publication Date: 2020-06-05
Lead Sponsor: Yale University
Collaborators: Genentech, Inc.
Intervention / Treatment: OTHER: Placebo, DRUG: Ocrelizumab
Lead Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany
Intervention / Treatment: DRUG: Cladribine Tablets